AcelRx (ACRX) Briefing Docs 'Positive', Expect Favorable Vote - Oppenheimer

October 10, 2018 12:24 PM
Oppenheimer analyst Leland Gershell weighed in on AcelRx Pharmaceuticals (NASDAQ: ACRX) following the FDA briefing documents, saying they read "positively ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments FDA

Next Articles